Reasons for global diagnostic preference as expressed by expert blinded neuroradiologists
| Specifications of Global Diagnostic Preference | Reader 1 (n = 66) | Preference Expressed Reader 2 (n = 79) | Reader 3 (n= 76) | |||
|---|---|---|---|---|---|---|
| Gadobenate Dimeglumine (n= 63) (%) | Gadodiamide (n= 3) (%) | Gadobenate Dimeglumine (n = 77) (%) | Gadodiamide (n = 2) (%) | Gadobenate Dimeglumine (n= 73) (%) | Gadodiamide (n = 3) (%) | |
| Superior contrast enhancement | 63 (95.5) | 2 (3.0) | 74 (93.7) | 2 (2.5) | 73 (96.1) | 3 (3.9) |
| Better delineation of normal structures | 0 | 0 | 7 (8.9) | 0 | 3 (3.9) | 0 |
| Better delineation of at least 1 lesion | 33 (50.0) | 1 (1.5) | 39 (49.4) | 0 | 44 (57.9) | 3 (3.9) |
| Better visualization of lesion internal structure | 10 (15.2) | 0 | 30 (38.0) | 0 | 19 (25.0) | 0 |
| Detection of more lesions | 3 (4.8) | 1 (1.5) | 3 (3.8) | 1 (1.3) | 2 (2.6) | 1 (1.3) |
| Greater diagnostic confidence | 10 (15.2) | 0 | 10 (12.7) | 1 (1.3) | 10 (13.2%) | 0 |